NAD+animalAnimal model2021

Maestro of the SereNADe: SLC25A51 Orchestrates Mitochondrial NAD.

Trends in biochemical sciences

confidence

Key findings

SLC25A51 identified as major mitochondrial NAD+ transporter; review of NAD+ biology, no clinical/biological endpoints reported.

View source on PubMed (PMID 33618948) ↗

Sample size
Not reported
Population
Mammalian cells (in vitro)
Dosing
Not reported
Duration
Not reported
Route
Not reported
Blinding
not_reported
Controls
none
Drug class
coenzyme
Full abstract

Recently, three groups, Girardi et al., Kory et al., and Luongo et al., independently identified solute carrier (SLC) 25A51 as the long-sought, major mitochondrial NAD+ transporter in mammalian cells. These studies not only deorphan an uncharacterized transporter of the SLC25A family, but also shed light on other aspects of NAD+ biology.

Research information, not medical advice. StudyKit summarizes published studies to help you understand your protocol. It does not diagnose, treat, or replace a clinician. Talk to a qualified provider before changing anything you take.